Skip Navigation LinksHome > May/June 2009 - Volume 16 - Issue 3 > Influence of a walking program on the metabolic risk profile...
Menopause:
doi: 10.1097/gme.0b013e31818d4137
Articles

Influence of a walking program on the metabolic risk profile of obese postmenopausal women

Roussel, Michel MSc1; Garnier, Sophie PhD1; Lemoine, Sophie PhD1; Gaubert, Isabelle MSc2; Charbonnier, Laurie Dt1; Auneau, Gérard PhD1,2; Mauriège, Pascale PhD1,3

Collapse Box

Abstract

Objective: Menopause transition is associated with an increased prevalence of metabolic syndrome (MS), which may partly explain the higher coronary heart disease risk. The aim of this study was to examine the impact of a 16-week walking program on the metabolic risk profile of women 50 to 65 years old whose body mass index ranged from 29 to 35 kg/m2.

Methods: A total of 153 postmenopausal women were subjected to three sessions per week of 45-minutes of walking at 60% of their heart rate reserve. At baseline, 46 and 84 women were characterized by one and two or more determinants of MS, respectively, whereas 23 women did not show this condition. Body composition, resting blood pressure, fasting lipid-lipoprotein profile, and cardiorespiratory fitness (CRF) were measured before and after exercise.

Results: In the whole sample of 153 women, CRF estimated by V˙o2max increased in response to walking (P < 0.0001). Endurance training promoted body weight and fat mass losses and reduced waist girth and blood pressure, whereas it decreased plasma triglyceride, cholesterol, and low-density lipoprotein cholesterol levels and increased high-density lipoprotein cholesterol concentrations (P < 0.0001). Improvements in lipid-lipoprotein levels were not associated with increases in CRF but seemed to be dependent on reduced body fatness. However, the greatest ameliorations in metabolic risk profile were found in women characterized by two or more determinants of MS at baseline than in the two other groups (0.05 < P < 0.0001).

Conclusion: A moderate-intensity physical activity is thus sufficient to reduce the metabolic risk profile of postmenopausal women characterized by the presence of one or several clinical features of MS but without overt coronary heart disease.

©2009The North American Menopause Society

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.